指南与共识胸部技术与安全CTDR

ACR适用性标准® 免疫功能低下患者的急性呼吸道疾病

ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients.
PubMed 文献 · J Am Coll Radiol · 2019-01-01

美国放射学会适用性标准针对免疫功能低下合并急性呼吸道疾病患者,基于文献分析与RAND/UCLA适用性方法及GRADE分级,由多学科专家组评定影像检查的适用性;当证据不足或模棱两可时,专家意见可补充证据以推荐影像或治疗。

要点

  • 免疫功能低下患者急性呼吸道疾病可表现为发热、寒战、体重下降、咳嗽、气短或胸痛。
  • 免疫功能低下患者常接受预防性或经验性抗微生物治疗,使诊断评估更复杂。
  • 非感染性病因也应考虑,包括肺水肿、药物性肺病、肺不张、恶性肿瘤等。

核心结论

  • 免疫功能低下患者急性呼吸道疾病病情进展迅速且可能致命,及时选择合适的影像检查非常重要。

研究设计与样本

  • 美国放射学会适用性标准为循证指南,由多学科专家组每年审查,制定与修订包括对同行评审期刊当前医学文献的广泛分析,并应用RAND/UCLA适用性方法和GRADE对特定临床场景的影像与治疗操作适用性进行评级;证据不足或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。

局限性

  • 原文指出在证据缺乏或模棱两可的情况下,专家意见可补充现有证据以推荐影像或治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The immunocompromised patient with an acute respiratory illness (ARI) may present with fever, chills, weight loss, cough, shortness of breath, or chest pain. The number of immunocompromised patients continues to rise with medical advances including solid organ and stem cell transplantation, chemotherapy, and immunomodulatory therapy, along with the continued presence of human immunodeficiency virus and acquired immunodeficiency syndrome. Given the myriad of pathogens that can infect immunocompromised individuals, identifying the specific organism or organisms causing the lung disease can be elusive. Moreover, immunocompromised patients often receive prophylactic or empiric antimicrobial therapy, further complicating diagnostic evaluation. Noninfectious causes for ARI should also be considered, including pulmonary edema, drug-induced lung disease, atelectasis, malignancy, radiation-induced lung disease, pulmonary hemorrhage, diffuse alveolar damage, organizing pneumonia, lung transplant rejection, and pulmonary thromboembolic disease. As many immunocompromised patients with ARI progress along a rapid and potentially fatal course, timely selection of appropriate imaging is of great importance in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking, or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Lee C, Colletti PM, Chung JH, et al. ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients. J Am Coll Radiol. 2019. PMID: 31685101. doi:10.1016/j.jacr.2019.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。